S. Kelly

754 total citations
12 papers, 541 citations indexed

About

S. Kelly is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, S. Kelly has authored 12 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pathology and Forensic Medicine. Recurrent topics in S. Kelly's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). S. Kelly is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). S. Kelly collaborates with scholars based in United States, Sweden and United Kingdom. S. Kelly's co-authors include Ian Lockhart, Sylvia Mitchell, René Westhovens, Peter Nash, Andrew Chalmers, David D’Cruz, Rubén Burgos‐Vargas, Leonard H. Sigal, Sang‐Cheol Bae and Yun Peng and has published in prestigious journals such as Annals of the Rheumatic Diseases, Dementia and Geriatric Cognitive Disorders and Clinical and Experimental Rheumatology.

In The Last Decade

S. Kelly

12 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Kelly United States 5 351 225 160 76 56 12 541
Ehab Mahgoub United States 12 208 0.6× 282 1.3× 91 0.6× 63 0.8× 51 0.9× 20 508
Kalle Aaltonen Finland 12 493 1.4× 248 1.1× 35 0.2× 182 2.4× 26 0.5× 32 681
Jeffrey D. Greenberg United States 8 132 0.4× 149 0.7× 55 0.3× 25 0.3× 16 0.3× 11 535
Е. Л. Насонов Russia 10 197 0.6× 89 0.4× 20 0.1× 67 0.9× 19 0.3× 46 342
Adam Young United Kingdom 11 362 1.0× 94 0.4× 11 0.1× 146 1.9× 32 0.6× 24 469
Mirit Amit-Vazina Israel 11 140 0.4× 90 0.4× 19 0.1× 57 0.8× 9 0.2× 14 368
Antonio G. Tristano Venezuela 11 203 0.6× 65 0.3× 14 0.1× 73 1.0× 43 0.8× 25 454
Kenichiro Matoba Japan 10 135 0.4× 45 0.2× 34 0.2× 66 0.9× 54 1.0× 13 344
Aleksandra Djoković Serbia 13 170 0.5× 54 0.2× 20 0.1× 76 1.0× 34 0.6× 38 423

Countries citing papers authored by S. Kelly

Since Specialization
Citations

This map shows the geographic impact of S. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kelly more than expected).

Fields of papers citing papers by S. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kelly. The network helps show where S. Kelly may publish in the future.

Co-authorship network of co-authors of S. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kelly. A scholar is included among the top collaborators of S. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kelly. S. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Harrold, Leslie R., Heather J. Litman, Seán Connolly, et al.. (2017). AB0408 Comparative effectiveness of abatacept versus tnfi in patients with rheumatoid arthritis who are ccp+ in the united states corrona registry. Annals of the Rheumatic Diseases. 76. 1192–1192. 2 indexed citations
3.
Bandyopadhyay, Soham, Seán Connolly, Omar Jabado, et al.. (2016). De-Convolution of Whole Blood Transcriptomic Data From a Phase Jib, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus. Clinical and Experimental Rheumatology. 34(4). 2463–2464. 1 indexed citations
4.
Harrold, Leslie R., Heather J. Litman, Seán Connolly, et al.. (2016). FRI0205 Relationship between Anti-Citrullinated Protein Antibody Status and Response To Abatacept or Anti-Tumour Necrosis Factor Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study. Annals of the Rheumatic Diseases. 75. 505–506. 2 indexed citations
5.
Harrold, Leslie R., Heather J. Litman, Seán Connolly, et al.. (2016). OP0178 Impact of Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor Status on Response To Abatacept Therapy: Findings from A US Observational Cohort. Annals of the Rheumatic Diseases. 75. 123–124. 4 indexed citations
6.
Connolly, Seán, Omar Jabado, S. Kelly, et al.. (2015). De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus. Queensland's institutional digital repository (The University of Queensland). 67. 1 indexed citations
7.
Alten, Rieke, Clifton O. Bingham, Stanley Cohen, et al.. (2013). SAT0001 Antibody Response to Pneumococcal and Influenza Vaccination in Patients With RA Receiving Subcutaneous Abatacept. Annals of the Rheumatic Diseases. 72. A579–A579. 2 indexed citations
8.
9.
Lockhart, Ian, Sylvia Mitchell, & S. Kelly. (2009). Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence. Dementia and Geriatric Cognitive Disorders. 28(5). 478–492. 77 indexed citations
10.
Merrill, JT, Rubén Burgos‐Vargas, René Westhovens, et al.. (2008). The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study. Queensland's institutional digital repository (The University of Queensland). 58(12). 4031–4032. 15 indexed citations
11.
Schiff, Michael, J. Eugene Huffstutter, Vicente Rodríguez‐Valverde, et al.. (2008). The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial. Annals of the Rheumatic Diseases. 68(11). 1708–1714. 123 indexed citations
12.
While, David, S. Kelly, Wei‐Chun Huang, & Andrew Charlton‐Perez. (1996). Cigarette advertising and onset of smoking in children: questionnaire survey. BMJ. 313(7054). 398–399. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ehab Mahgoub Breakdown of academic impact, for papers by Kalle Aaltonen Breakdown of academic impact, for papers by Jeffrey D. Greenberg Breakdown of academic impact, for papers by Е. Л. Насонов Breakdown of academic impact, for papers by Adam Young Breakdown of academic impact, for papers by Mirit Amit-Vazina Breakdown of academic impact, for papers by Antonio G. Tristano Breakdown of academic impact, for papers by Kenichiro Matoba Breakdown of academic impact, for papers by Aleksandra Djoković
Rankless by CCL
2026